Morales, Anecita .

HRN: 29-11-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/08/2026
06/15/2026
IV
600mg
Q6
Cellulitis
Remove - Pending Acceptance
06/08/2026
CEFTRIAXONE 1G (VIAL)
06/08/2026
06/15/2026
IV
2g
Od
Cuti
Remove - Pending Acceptance
06/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2026
06/19/2026
IV
2.25g
Q8h
CELLULITIS
Remove - Pending Acceptance
06/12/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/12/2026
06/19/2026
IV
600mg
Q6h
Cellulitis
Remove - Pending Acceptance
06/13/2026
MUPIROCIN 2%, 15G (TUBE)
06/13/2026
06/19/2026
TOPICAL
Apply Thinly On Affected Area
BID
Cellulitis, Right Leg
Checking Initial Appropriateness 
06/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/13/2026
06/19/2026
IV
500mg
Q8h
Spontaneous Bacterial Peritonitis
Checking Initial Appropriateness 
06/21/2026
OXACILLIN 500MG (VIAL)
06/21/2026
06/21/2026
IV
2g
Q4H
Cellulitid
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: